Skip to main content
MTEX
NASDAQ Life Sciences

Director Buys $29.6K in MTEX Shares Following Q1 Turnaround

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
7
Price
$3.98
Mkt Cap
$7.68M
52W Low
$3.895
52W High
$12.454
Market data snapshot near publication time

summarizeSummary

A director of Mannatech Inc. purchased $29,607 worth of common stock in the open market, signaling confidence after the company reported a Q1 financial turnaround and while facing a Nasdaq delisting threat.


check_boxKey Events

  • Director Open Market Purchase

    Kevin Andrew Robbins, a director, acquired 7,100 shares of common stock for $29,607 at an average price of $4.17 per share.

  • Timing Amidst Financial Turnaround

    This purchase occurred on May 19, 2026, just days after Mannatech reported a significant Q1 2026 net profit and positive operating cash flow, contrasting with previous losses and a "going concern" warning.

  • Stock Trading Near 52-Week Lows

    The transaction took place while the company's stock is trading near its 52-week low, potentially indicating the director sees value at current levels.

  • Context of Delisting Threat

    The purchase comes as Mannatech continues to address a Nasdaq delisting notice received on April 24, 2026, for failing to meet minimum stockholders' equity requirements.


auto_awesomeAnalysis

This open market purchase by a director is notable given Mannatech's recent volatile financial situation. The company recently reported a significant Q1 turnaround with a net profit and positive operating cash flow, which is a crucial development after facing a "going concern" warning and a Nasdaq delisting notice. A director buying shares, particularly when the stock is near its 52-week low and after a positive earnings report, suggests a belief in the company's recovery efforts and future prospects, despite the ongoing challenges.

At the time of this filing, MTEX was trading at $3.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $3.90 to $12.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MTEX - Latest Insights

MTEX
May 20, 2026, 2:37 PM EDT
Filing Type: 4
Importance Score:
7
MTEX
May 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
May 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
MTEX
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
MTEX
Apr 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
Apr 24, 2026, 11:55 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
MTEX
Apr 21, 2026, 1:29 PM EDT
Filing Type: DEF 14A
Importance Score:
9
MTEX
Apr 15, 2026, 5:15 PM EDT
Source: Wiseek News
Importance Score:
9
MTEX
Apr 15, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
9
MTEX
Apr 15, 2026, 5:08 PM EDT
Filing Type: 10-K
Importance Score:
10